Abstract

Shikonin (SKN), a highly liposoluble naphthoquinone pigment isolated from the roots of Lithospermum erythrorhizon, is known to exert antibacterial, wound-healing, anti-inflammatory, antithrombotic, and antitumor effects. The aim of this study was to examine SKN antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA). The SKN was analyzed in combination with membrane-permeabilizing agents Tris and Triton X-100, ATPase inhibitors sodium azide and N,N′-dicyclohexylcarbodiimide, and S. aureus-derived peptidoglycan; the effects on MRSA viability were evaluated by the broth microdilution method, time-kill test, and transmission electron microscopy. Addition of membrane-permeabilizing agents or ATPase inhibitors together with a low dose of SKN potentiated SKN anti-MRSA activity, as evidenced by the reduction of MRSA cell density by 75% compared to that observed when SKN was used alone; in contrast, addition of peptidoglycan blocked the antibacterial activity of SKN. The results indicate that the anti-MRSA effect of SKN is associated with its affinity to peptidoglycan, the permeability of the cytoplasmic membrane, and the activity of ATP-binding cassette (ABC) transporters. This study revealed the potential of SKN as an effective natural antibiotic and of its possible use to substantially reduce the use of existing antibiotic may also be important for understanding the mechanism underlying the antibacterial activity of natural compounds.

Highlights

  • Among the emerging multidrug-resistant bacteria, methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial infections and is considered a great public health problem worldwide [1]

  • Few new drugs are available against MRSA strains, which are resistant to most antibiotics [27]

  • The search for new and effective antimicrobial agents and/or novel therapeutic approaches for the treatment of infectious diseases caused by drug-resistant bacteria including

Read more

Summary

Introduction

Among the emerging multidrug-resistant bacteria, methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of nosocomial infections and is considered a great public health problem worldwide [1]. An outbreak of MRSA infection caused by a novel phage-type of S. aureus occurred in three hospitals in Evidence-Based Complementary and Alternative Medicine the United States over a 21-month period [9]. Glycopeptidetype drugs such as vancomycin have proven to be effective antimicrobial agents against most MRSA strains; vancomycin resistance of an S. aureus clinical isolate was reported in Japan shortly in 1997 [10]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call